A Self-Degradable Conjugated Polymer for Photodynamic Therapy with Reliable Postoperative Safety

As a noninvasive therapeutic technique, photodynamic therapy (PDT) has attracted numerous research interests for cancer therapy. Nevertheless, the residual photosensitizers (PSs) still produce reactive oxygen species (ROS) and damage normal cells under sunlight after PDT, which limits their practical application in clinic. Herein, the authors propose a self-degradable type-I PS based on conjugated polymer, which is composed of aggregation-induced emission (AIE) and imidazole units. Due to the effective conjugated skeleton and unique AIE properties, thus-obtained polymers can effectively generate superoxide radical (O-2(-center dot)) through the type-I process under light irradiation, which is ideal for hypoxic tumors treatment. Intriguingly, under light irradiation, O-2(-center dot) produced by the conjugated polymers can further lead to the self-degradation of the polymer to form nontoxic micro-molecules. It not only helps to resolve the potential phototoxicity problems of residual PSs, but also can accelerate the metabolism of the conjugated polymers to avoid the potential biotoxicity of drug accumulation. This work develops a self-degradable type-I PS, which can turn off the generation of ROS in time after PDT, providing a novel strategy to balance the PDT effect and postoperative safety.

Automated summary

In this study, a self-degradable type-I photosensitizer based on conjugated polymers was developed, which can effectively generate superoxide radicals under light irradiation and further degrade into nontoxic micro-molecules. This strategy helps to address the phototoxicity issues of residual photosensitizers and accelerate the metabolism of conjugated polymers, enhancing postoperative safety.